drugset / Trial / NCT03400501

Reducing the Risk of Metabolic Decompensation in Diabetic Adolescents by Supervised School Administration of Insulin

NCT03400501

Phase 0 Completed 32 enrolled Yale University
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a pilot study to examine and compare the efficacy of supervised injections of long acting insulins degludec and glargine to protect youth with poorly controlled type 1 diabetes (T1D) from development of ketones.

Timeline

Start
2017-10-01
Primary completion
2021-06-07
Completion
2021-06-07

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin degludec Protein / enzyme biologic
Comparator insulin glargine Protein / enzyme biologic